Compositions and methods for the treatment of cardiovascular disease
Details for Australian Patent Application No. 2007243282 (hide)
International Classifications
Event Publications
20 November 2008 PCT application entered the National Phase
PCT publication WO2007/127377 Priority application(s): WO2007/127377
27 November 2008 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Relolvyx Pharmaceuticals, Inc., Application No. 2007243282, under INID (71), correct the name to read Resolvyx Pharmaceuticals, Inc.
19 November 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Resolvyx Pharmaceuticals, Inc., Application No. 2007243282, under INID (54) correct the title to read Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease.
20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007243286-Delta-8 desaturase and its use in making polyunsaturated fatty acids
2007243280-Formulations containing pyridazine compounds for treating neuroinflammatory diseases
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser